We have located links that may give you full text access.
Epidemiology of Emergency Department Visits for Anxiety in the United States: 2009-2011.
OBJECTIVE: The purpose of this study was to describe the epidemiology of anxiety-related emergency department (ED) visits in the United States and assess the care provided during those visits.
METHODS: Data from the 2009-2011 National Hospital Ambulatory Medical Care Survey were used to identify all ED visits in which the patient received a primary anxiety diagnosis or declared anxiety as the reason for the visit (N=1,029). Patient characteristics, treatment provided, and dispositions of these nationally representative visits were assessed.
RESULTS: There were an estimated 1,247,000 anxiety-related ED visits annually, representing .93% of all ED visits. The proportion of total ED visits that were anxiety related was higher among women than men (1.05% versus .77%) and among nonelderly adults (1.28%) versus other age groups, non-Hispanic whites (1.06%) versus other racial-ethnic groups, and self-pay visits (1.20%) versus other forms of insurance. Among anxiety-related visits, a small percentage (9.6%) involved admission to the hospital, and approximately 67% involved a referral back to the patient's medical care professional. Regarding content of care, most visits for anxiety involved diagnostic or screening services, and one-fourth involved medical procedures. Anxiolytics and benzodiazepines were prescribed most often when drug therapy was offered during anxiety visits in the ED.
CONCLUSIONS: EDs were frequently used by patients experiencing anxiety symptoms. In the vast majority of visits, follow-up visits with providers were planned. The most common treatment provided during these ED visits was benzodiazepines, which can offer immediate anxiety symptom relief but are potentially dangerous because of risk of overdose and addiction.
METHODS: Data from the 2009-2011 National Hospital Ambulatory Medical Care Survey were used to identify all ED visits in which the patient received a primary anxiety diagnosis or declared anxiety as the reason for the visit (N=1,029). Patient characteristics, treatment provided, and dispositions of these nationally representative visits were assessed.
RESULTS: There were an estimated 1,247,000 anxiety-related ED visits annually, representing .93% of all ED visits. The proportion of total ED visits that were anxiety related was higher among women than men (1.05% versus .77%) and among nonelderly adults (1.28%) versus other age groups, non-Hispanic whites (1.06%) versus other racial-ethnic groups, and self-pay visits (1.20%) versus other forms of insurance. Among anxiety-related visits, a small percentage (9.6%) involved admission to the hospital, and approximately 67% involved a referral back to the patient's medical care professional. Regarding content of care, most visits for anxiety involved diagnostic or screening services, and one-fourth involved medical procedures. Anxiolytics and benzodiazepines were prescribed most often when drug therapy was offered during anxiety visits in the ED.
CONCLUSIONS: EDs were frequently used by patients experiencing anxiety symptoms. In the vast majority of visits, follow-up visits with providers were planned. The most common treatment provided during these ED visits was benzodiazepines, which can offer immediate anxiety symptom relief but are potentially dangerous because of risk of overdose and addiction.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app